Antifungal medication :: Consumers survey results of for 4 quarter of 2010

Consumers survey results of for 4 quarter of 2010 in category

Dermatology, means for external use / Antifungal medication

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.		Lamisil (Novartis OTC)	37.04%	5

2.	6	Lamikon (Farmak)	22.22%	3

2.	3	Нітрофунгін (Teva)	22.22%	3

4.	6	Кандібене (ratiopharm)	18.52%	2.50

4.	7	Флюконазол (Norton)	18.52%	2.50

6.	3	Екзодерил (Sandoz)	14.81%	2

6.	2	Клотримазол (Борщагівський ХФЗ)	14.81%	2

6.	~	Клотримазол Гексал (Sandoz)	14.81%	2

6.		Мікосист (Gedeon Richter)	14.81%	2

10.	7	Мікогал (Teva)	11.11%	1.50

10.	7	Тримістин-Дарниця (Darnitsa)	11.11%	1.50

12.	6	Антифунгін (Монфарм)	7.41%	1

12.	6	Кетоконазол (Фітофарм)	7.41%	1

12.	6	Мікосептин (Zentiva)	7.41%	1

12.	~	Міфунгар (Zentiva)	7.41%	1

12.		Теймурова паста (Ternopharm)	7.41%	1

12.	~	Флуконазол (Red star)	7.41%	1

18.	~	Viosept (Jelfa)	3.70%	0.50

18.	6	Еконазол (Red star)	3.70%	0.50

18.	7	Канестен (Bayer)	3.70%	0.50

18.	~	Клотримазол (ORGANOSYN)	3.70%	0.50

18.	~	Клотримазол-Фітофарм (Фітофарм)	3.70%	0.50

18.	7	Мікомакс (Zentiva)	3.70%	0.50

18.	7	Міконазол (Elegant India)	3.70%	0.50

18.	5	Міконазол-Дарниця (Darnitsa)	3.70%	0.50

18.	6	Травоген (Bayer)	3.70%	0.50

18.	7	Ундецин (Arterium Corporation)	3.70%	0.50

18.	4	Флуконазол (Pharmaceutical company “Zdorovya”)	3.70%	0.50

–.	4	Zalain (Egis Pharmaceuticals)	0.00%	0

–.		Екодакс (Johnson & Johnson)	0.00%	0

–.		Клотрисал-КМП (Arterium Corporation)	0.00%	0

–.	7	Мікогель-КМП (Arterium Corporation)	0.00%	0

–.		Міконазол Гексал (Sandoz)	0.00%	0

–.	6	Мікоспор (Bayer)	0.00%	0

–.	7	Тербінокс (Johnson & Johnson)	0.00%	0

–.		Флуконазол (Vitaminy)	0.00%	0

–.		Флуконазол (Астрафарм)	0.00%	0

–.	6	Фунготербін (Nizhpharm)	0.00%	0

–.	7	Цинкундан (Arterium Corporation)	0.00%	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2010, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.